World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12615000268549
Date of registration: 23/03/2015
Prospective Registration: Yes
Primary sponsor: Dermatology Research Centre, School of Medicine, University of Queensland
Public title: Efficacy of Smartphone applications in diagnosing and detecting melanoma
Scientific title: For a patient with naevi, do smart phone applications when compared to diagnosis by gold standard histo-pathological report/dermatologist provide an effective way for individuals to self-detect melanoma.
Date of first enrolment: 02/04/2015
Target sample size: 30
Recruitment status: Completed
URL:  https://anzctr.org.au/ACTRN12615000268549.aspx
Study type:  Interventional
Study design:  Purpose: Diagnosis; Allocation: Non-randomised trial;  
Phase:  Not Applicable
Countries of recruitment
Australia
Contacts
Name: Mrs Elizabeth Payne   
Address:  Dermatology Research Centre Level 5, Translational Research Institute 37 Kent St, Woolloongabba, QLD, 4102 Australia
Telephone: +61 07 3443 7397
Email: e.payne@uq.edu.au
Affiliation: 
Name: Mrs Elizabeth Payne   
Address:  Dermatology Research Centre Level 5, Translational Research Institute 37 Kent St, Woolloongabba, QLD, 4102 Australia
Telephone: +61 07 3443 7397
Email: e.payne@uq.edu.au
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: Patients with suspected melanoma and/or clinically benign lesions
Exclusion criteria: No suspected melanoma or clinically benign lesions

Age minimum: 18 Years
Age maximum: No limit
Gender: Both males and females
Health Condition(s) or Problem(s) studied
melanoma;
melanoma
Cancer - Non melanoma skin cancer
Skin - Dermatological conditions
Cancer - Malignant melanoma
Intervention(s)
Study of the efficacy of use of Dr Mole, Skinvision and Spotmole Plus smartphone applications in the self diagnosis of melanoma from images of naevi. Photos of naevi will be taken by smartphones. A dermatology consultation will determine if lesions are suspicious or benign. For patients with suspicious lesions, photos will be taken prior to the traditional dermatological intervention involving excision of the lesion. The smartphone photo's will be submitted to each of the smartphone applications for evaluation. The smartphone application evaluations will then be compared to the histo-pathological report and dermatologist diagnosis for suspect lesions, and to the dermatologist diagnosis for benign lesions (as no histo-pathological diagnosis will be available for benign lesions).
Primary Outcome(s)
Statistically significant results from analysis of outcomes of original image evaluations by the smartphone applications compared to gold standard histo-pathological reports/dermatologist diagnosis. Overall sensitivity, specificity, positive predictive value and negative predictive value for each application will be determined. McNemar chi-square test will be used to compare the respective sensitivities of the various smartphone applications. This is a composite primary outcome to determine the overall accuracy of the smartphone applications in detecting suspicious lesions.[Primary timepoint is when the smartphone application evaluation of the smartphone naevi photo is compared to the gold standard histo-pathological report/dermatologist diagnosis of the same naevi]
Secondary Outcome(s)
Statistically significant results from analysis of outcomes of smartphone photo's taken from high quality printouts of original images (original smartphone photos of the actual naevi on the patient), with evaluations by the smartphone applications compared to gold standard histo-pathological report/dermatologist diagnosis. Overall sensitivity, specificity positive predictive value and negative predictive value for each application will be determined. McNemar chi-square test will be used to compare the respective sensitivities of the various smartphone applications. This is a composite secondary outcome to determine the overall accuracy of the smartphone applications for detecting suspicious lesions when using smartphone photos of high quality printouts of the original naevi photos (rather than the original naevi photos taken and used in Primary Outcome 1).[High quality print outs of the original naevi photo's will be made. Smartphone photo's of these print outs will be taken and submitted to the smartphone applications for evaluation. These secondary photo evaluations by the smartphone applications with be compared to the gold standard histo-pathological report/dermatologist diagnosis of the same naevi.]
Secondary ID(s)
Nil
Source(s) of Monetary Support
Dermatology Research Centre, School of Medicine, University of Queensland
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date:
Contact:
Metro South Human Research Ethics Committee
Status: Approved
Approval date:
Contact:
University of Queensland Institutional Human Research Ethics Committee
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history